肾复康汤治疗乙肝病毒相关性肾炎的临床效果分析  

An effective analysis of treating hepatitis B virus-associated glomerulonephritis with the Shenfukang decoction

作　　者：蔡本强[1] 

机构地区：[1]深圳市中医院,广东深圳518000

出　　处：《中医临床研究》2017年第11期77-78,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的:探讨肾复康汤治疗乙肝病毒相关性肾炎的临床效果。方法:选取我院2015年3月-2016年5月收治的102例乙肝病毒相关性肾炎患者作为研究对象,将其随机分为观察组(56例)及对照组(46例),对照组行常规西药治疗,观察组在常规治疗的基础上口服肾复康汤,对比两组患者治疗前后的肝、肾功能及HBV-DNA、24h尿蛋白定量及治疗效果。结果:观察组的治疗总有效率为92.8%,显著高于对照组的65.2%(P<0.05);观察组治疗后的各项生化指标与24h尿蛋白的检测结果及HBV-DNA转阴率均显著优于对照组(P<0.05)。结论:乙肝病毒相关性肾炎患者在西药治疗的基础上配合肾复康汤治疗临床疗效显著且安全,值得推广。Objective:To investigate clinical effects of the Shenfukang decoction on hepatitis B virus-associated glomerulonephritis.Methods:102patients who were treated in our hospital from March2015to May2016were randomly divided into the observation group(56cases)and control group(46cases).The control group took routine western medicine;the observation group received the Shenfukangdecoction more.Liver and kidney function,HBV-DNA,24h urine protein quantitative and therapeutic effects in the groups before andafter were compared.Results:The total efficiency was92.8%in the observation group,significantly higher than65.2%in the control group(P<0.05).The biochemical indexes and24h urinary protein after treatment in the observation group were significantly higher than those inthe control group,P<0.05.Conclusion:Treating hepatitis B virus-associated glomerulonephritis with the Shenfukang decoction on the basisof western medicine showed significantly clinical efficacy,is safe and worthy of clinical promotion.

关 键 词：肾复康汤 乙肝病毒 肾小球 乙肝病毒相关性肾炎 临床效果 

分 类 号：R692.31[医药卫生—泌尿科学]